Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Characteristics of a population-based MS cohort treated with DMDs Next Article
Tackling unmet MS-related cognitive challenges »
« Characteristics of a population-based MS cohort treated with DMDs Next Article
Tackling unmet MS-related cognitive challenges »
Related Articles
December 16, 2020
Characteristics of a population-based MS cohort treated with DMDs
December 16, 2020
No increased risk with IFN-β use during pregnancy
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy